Chief Financial Officer · Beta Bionics, Inc. · Common Stock
Side
M
Value
$25K
Shares
4,982
Price
$5.1
Executed
Jun 26, 2026
Disclosed
Jun 30, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Jun 26 executedJun 30, 2026 disclosed
BBNX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
$25K reported value · 3.0% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
3 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Feider Stephen filed this Form 4 reporting a option exercise of BBNX on Jun 26, 2026. It became public on Jun 30, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Feider Stephencik:0002048588
Issuer
Beta Bionics, Inc.cik:0001674632
Revision history · 0
No field has changed since this record was first ingested.
